Cluster of differentiation 24 (CD24), a heavily glycosylated mucin-type glycosylphosphatidylinositol-anchored cell surface molecule, has been verified as highly presented and associated with poor outcomes in human cancers [8]. This evidence concerns the gene CD24 and cancer.